yamanouchi pharmaceutical co ltd annual report 2003 contents message from management 1 an interview with the president 4 research and development 10 presence in japan 14 urology driving growth 18 corporate citizenship 22 environmental protection 23 board of directors 24 cautionary statement regarding forward looking information this includes statements based on a number assumptions beliefs light currently available to subject significant risks uncertainties actual financial results may differ materially depending factors including adverse economic conditions currency exchange rate fluctuations legislative regulatory developments delays new product launches pricing initiatives competitors inability company market existing products effectively interruptions production infringements s intellectual property rights outcome material litigation philosophy creating caring for life that contribute well being people everywhere goal become oriented r&d driven global enterprise pursuit future prosperity accelerate clinical start our own sales activities us turn profitable quickly bolster genomics discovery growing profits expand
